Navigation Links
The Galien Foundation Debuts 2017 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories

NEW YORK, July 26, 2017 /PRNewswire/ -- The Galien Foundation announced today the 2017 11th Annual Prix Galien USA Award Nominees. Counted among the global health innovation industry's most prized honors, the Prix Galien Award recognizes outstanding biomedical and technology product achievement that improves the human condition.

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for market within the last five years and demonstrate tremendous potential to impact human health. Sales data are not considered by the nominating committee in their award nominee selection; only science and health impact.

"The 2017 nominees are working each day to ensure a healthier future for the next generation," said Dr. P. Roy Vagelos, chairman, Prix Galien USA Awards Committee, and prior recipient of the Pro Bono Humanum Award. "The selection committee appreciates the unwavering devotion by the teams of researchers, scientists and innovators that have dedicated their lives to such a worthy cause, and we are honored to recognize their achievements."

The Prix Galien USA 2017 nominees include in-market products evaluated in the following categories: "Best Biotechnology Product" – 15 nominees; "Best Pharmaceutical Agent" – 34 nominees, and "Best Medical Technology" – 11 nominees.

Best Biotechnology Product (Nominees)

Alexion Pharmaceuticals Inc.

Kanuma® Alexion Pharmaceuticals Inc.

Strensiq® Amgen Inc.

IMLYGIC® Amgen Inc.

Repatha®Biogen & Ionis Pharmaceuticals

SPINRAZA™Boehringer Ingelheim

Praxbind®Eli Lilly and Company

CYRAMZA® Eli Lilly and Company

LARTRUVO™ Genentech, a Member of the Roche Group

Kadcyla®GlaxoSmithKline plc

Benlysta®Merck & Co., Inc.

Zinplava™Onyx Pharmaceuticals Inc. & Amgen Inc.

Blincyto®Pfizer Inc.

Trumenba®Regeneron and sanofi

PRALUENT®Sarepta Therapeutics, Inc.


Best Pharmaceutical Agent (Nominees)

AbbVie Inc.

Duopa™AbbVie Inc.

Technivie™AbbVie Inc.

Venclexta™ACADIA Pharmaceuticals Inc.

NUPLAZID®Allergan, Inc.

Dalvance®Allergan, Inc.

Kybella®Allergan, Inc.




Tagrisso®Boehringer Ingelheim

Jardiance®Boehringer Ingelheim

OFEV®Bristol-Myers Squibb Company

Daklinza™Eisai Inc.

Halaven®Eisai Inc.

Lenvima®Endoceutics, Inc.

Intrarosa™Genentech, a Member of the Roche Group

Alecensa®Genentech, a Member of the Roche Group


Harvoni®Helsinn Therapeutics Inc. & Eisai Inc.

Akynzeo®Iroko Pharmaceuticals, LLC

Vivlodex™Janssen Pharmaceutical Companies

DARZALEX™Janssen Pharmaceutical Companies

YONDELIS®Jazz Pharmaceuticals

Defitelio®LEO Pharma Inc.

Enstilar®Merck & Co., Inc.


ZYKADIA®Otsuka Pharmaceutical Co., Ltd.

Rexulti®Pfizer Inc.

XELJANZ®Pfizer Inc. and Astellas

Xtandi®Shire plc

Xiidra®The Medicines Company

Orbactiv®UCB, Inc.



Best Medical Technology (Nominees)


CardioMEMS™ HF SystemAllergan, Inc.

Juvederm Volbella® XCBiosense Webster

SMARTTOUCH® Surround Flow Catheters and The CARTO
SMARTTOUCH™ Software Module    Boston Scientific

SpyGlass DS™ Direct Visualization System Boston Scientific

WATCHMAN™ Left Atrial Appendage Closure DeviceBrainScope Company, Inc.

BrainScope® OneINSIGHTEC

Exablate NeuroIntegra LifeSciences

Omnigraft™ Dermal Regeneration MatrixJohnson & Johnson - DePuy Synthes

ATTUNE® Knee SystemJohnson & Johnson - Ethicon

EVARREST® Fibrin Sealant PatchKoning Corporation

Koning Breast CT 1000

"As the realm of scientific discovery and medical innovation shuttles forward, we were thrilled to see so many high-caliber submissions this year," said Bruno Cohen, chairman of the Galien Foundation.  "Our Foundation is continually impressed by the achievement of the Prix Galien candidates each year, but 2017 has become a benchmark for future years."

The Prix Galien USA Committee is comprised of thirteen renowned leaders from the biomedical industry and academia, including four Nobel Laureates, responsible for evaluating nominees. Winners will be announced during the Prix Galien USA Awards Ceremony on October 26, 2017, at the American Museum of Natural History in New York City.  Registration to attend the 2017 Prix Galien USA Awards Ceremony can be accessed here.

Prix Galien Awards Committee 2017Pr Richard AXEL,
M.D. Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York

Pr Michael S. BROWN,
M.D. Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center, Dallas, TX

M.D., M.Ph. Chief Executive Officer of the Bill & Melinda Gates Foundation, Seattle, WA

M.D. Chief Executive Officer and President, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School

M.D. Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center, Dallas, TX

Pr Robert S. LANGER,
M.D. David H. Koch Institute Professor at MIT

M.D., Ph.D. University Professor, University of Connecticut, CT

Pr Paul A. MARKS,
M.D. Laboratory Head of Cell Biology Memorial Sloan Kettering Cancer Center, New-York. President Emeritus, MSKCC

Ph.D. Professor of Bioengineering, Malcolm Gillis University, Houston, TX

M.D. Chief Medical Officer of Flagship Ventures, Cambridge, MA

Pr Bengt SAMUELSSON, M.D., Ph.D. Nobel Laureate, Former President of Karolinska Institute and Former Chairman of the Nobel Foundation

Ph.D. President, Stanford University, Stanford, CA

M.D. Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, Regeneron Pharmaceuticals, Inc. Committee Chairman

About The Galien Foundation The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

For more information, visit

Galien Foundation Media Contact:
Giana Gregga
Finn Partners

View original content with multimedia:

SOURCE The Galien Foundation
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
2. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
3. The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
4. Stryker erhält prestigeträchtigen 2014 Prix Galien Award für die beste medizinische Technologie
5. Stryker reçoit le prestigieux Prix Galien 2014 pour la meilleure technologie médicale
6. The Galien Foundation Announces Partnership with Business France to Foster US-France Life Sciences Innovation via MedStartUp Program
7. The Prix Galien Russia Selection Committee Honors Excellence in Scientific Innovation at 2016 Prix Galien Russia Awards Gala
8. National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill
9. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinsons Disease
10. Betty Ford Center, Hazelden Foundation Pursue Possible Alliance
11. W.K. Kellogg Foundation announces Mission Driven Investment in SeeChange Health
Post Your Comments:
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... $3,296 in property taxes a year. In some states—like New York, New Jersey, ... By contrast, many overseas retirement havens have extremely low property-tax rates, which contributes ...
Breaking Medicine News(10 mins):